LIFE-VENUS Study

【研究代表者】小野玲
【研究資金】文部科研：基盤研究（C） [2022-2024]

地域在住高齢がんサバイバーコホートの構築：健康寿命延伸に向けて

【研究代表者】中尾智博
【研究資金】厚労科研：障害者政策研究事業 [2022-2024]

新型コロナウイルス感染に起因すると考えられる精神症状に関する疫学的検討と支援策の検討に資する研究

【研究代表者】佐藤大介
【研究資金】文部科研：基盤研究（B） [2021-2025]

指定難病と医療介護データの統合による経時的解析可能な難病データベース基盤の開発

【研究代表者】飯原弘二
【研究資金】AMED：循環器疾患・糖尿病等生活習慣病対策実用化研究事業 [2019-2020]

脳卒中のQOLと医療経済評価法の開発に関する研究

Kawabata J, Goto K*, Maeda M, Fukuda H.

Comparison of post-discharge mortality and medical expenditures in COVID-19 patients according to mechanical ventilation and extracorporeal membrane oxygenation use: The LIFE Study.

Plos One 2026; 21(3): e0345939.

Murata S*, Ebeling M, Ono R, Maeda M, Schmidt‑Mende K, Fukuda H*, Modig K. Understanding Japan’s Mortality Advantage:

Understanding Japan’s mortality advantage: a comparison of mortality in independent and dependent older adults in Japan and Sweden.

BMC Medicine 2026; 24(1): 160.

Kinugawa A, Takeuchi K, Tamada Y, Kusama T, Oda F, Maeda M, Ohyama H, Osaka K, Fukuda H.

Impact of Leaving Periodontal Disease Untreated on Healthcare Expenditures: A Retrospective Cohort Study.

Journal of Periodontology 2026; in press.

Okui T*, Fukushima H, Maeda M, Oda F, Nakashima N, Fukuda H.

A short-term association between hospitalizations for mental disorders and ambient temperature in Japan: an ecological study using the LIFE Study data.

Environmental Health and Preventive Medicine 2026; 31: 12.

Shida H, Hirayama A, Kitamura T, Maeda M, Oda F, Fukuda H, Kawasaki R*.

Association between the care need level before admission and long-term outcomes in elderly patients with stroke: The Longevity Improvement & Fair Evidence (LIFE) study.

Journal of the American Medical Directors Association 2026; 27: 106165.

Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H*.

Development and validation of a machine learning model for frailty screening using claims data in Japan: the Longevity Improvement & Fair Evidence Study.

Experimental Gerontology 2026; 215(2026): 113050.

Nakatsuka K, Ono R, Maeda M, Murata F, Fukuda H.

Long-term habitual physical activity and risk of mortality and long-term care insurance certification in cancer survivors: a prospective cohort study in the LIFE Study, Japan.

BMJ Open 2026; 16: e104102.

Sung Y, Goto K*, Akeno Y, Maeda M, Murata F, Fukuda H.

Sleep maintenance efficiency measured by multi-sensor wristband devices and its association with blood pressure: the LIFE Study.

Digital Health 2026; 12: 205520762614208752026.

Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H*.

Initial real-world experience with lecanemab prescribing patterns in Japan: the Longevity Improvement & Fair Evidence (LIFE) Study.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026: 18(1):e70273.

Katsuta T*, Sato S, Kawazoe Y, Fukuda H.

Active vaccine safety monitoring system using health insurance claims data in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.

Vaccine 2026; 74: 128209.

中塚清将, 小野玲, 前田恵, 小田太史, 福田治久.

特定健診受診者における運動推奨ダイレクトメッセージと健康行動の関連：LIFE Studyによるランダム化比較試験の2次利用.

第27回日本健康支援学会年次学術大会. 2026年3月6-7日. 松江.

明野由里奈, 後藤健一, 前田恵, 小田太史, 福田治久.

特定保健指導の保健師別パフォーマンス評価の試み：LIFE Study.

第27回日本健康支援学会年次学術大会. 2026年3月6-7日. 松江.

緒方大聡, 前田恵, 小田太史, 岡本勇, 福田治久.

慢性閉塞性肺疾患に対する単一吸入器トリプル製剤間の服薬アドヒアランスの比較：LIFE Study.

第66回日本呼吸器学会学術講演会.2026年4月17日-19日. 神戸.

Ogata H, Maeda M, Oda F, Okamoto I, Fukuda H.

Real-World Evaluation of Medication Adherence to Single-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease: The LIFE Study.

American Thoracic Society Conference 2026. 2026年5月17-20日. Orland.

Maeda H, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H.

Incidence of COVID-19 Hospitalization and Seizures by Vaccination in Youth in Japan: VENUS Study.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.

Zha L, Kimura Y, Komatsu M, Shimomura Y, Gon Y, Maeda M, Oda F, Komukai S, Kiyohara K, Kitamura T, Fukuda H.

Association of PPSV23 with Parkinson’s and Alzheimer’s Disease Risk: The VENUS Study.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.

Sung Y, Goto K, Maeda M, Oda F, Fukuda H.

Bias in vaccination coverage from incomplete in-migrant records in Japan: the VENUS Study.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.

Chikamochi S, Mimura W, Ishiguro C, Oda F, Maeda M, Fukuda H.

Effect of missing Enrollment Registry on Vaccine Effectiveness based on NDB’s feature: VENUS Study.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, NagasakiJanuary 28-30, 2026.

Kono Y, Ishiguro C, Hagiwara Y, Fukuda H, Takeuchi Y.

Selection bias in the test-negative case-control design.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.

Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H.

Initial real-world experience with lecanemab prescribing pattern in Japan: The LIFE Study.

The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki January 28-30, 2026.